SKYE Gross Margin

The Gross Margin of Skye Bioscience Inc (SKYE) is 35.29%.

Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.

SKYE Gross Margin - Historical Value

Date	Value
2024-12-31	35.29%

SKYE Gross Margin - Peers Comparison

Ticker	Name	Value
PTIX	Protagenic Therapeutics Inc	43.75%
TELO.V	Telo Genomics Corp	7775.20%
VIRI	Virios Therapeutics Inc	7775.20%
INTI	Inhibitor Therapeutics Inc	19.44%
PMN.TO	ProMIS Neurosciences Inc	7775.20%
PSTV	Plus Therapeutics Inc	64.36%
QPT.V	Quest Pharmatech Inc	54.39%
TENX	Tenax Therapeutics Inc	100.00%
ENZN	Enzon Pharmaceuticals Inc	72.28%
LIXT	Lixte Biotechnology Holdings Inc	7775.20%
QBIO	Q BioMed Inc	-3.57%
LIFE	aTyr Pharma Inc	7775.20%
NAVB	Navidea Biopharmaceuticals Inc	-171.43%
PKTX	ProtoKinetix Inc	7775.20%
BTI.V	Bioasis Technologies Inc	100.00%
CRYO	American Cryostem Corp	34.09%
GOVX	GeoVax Labs Inc	25.00%
BRTX	BioRestorative Therapies Inc	93.00%
GNBT	Generex Biotechnology Corp	78.21%
NNVC	NanoViricides Inc	7775.20%
XBIO	Xenetic Biosciences Inc	97.89%
ADTX	Aditxt Inc	-368.30%
BNTC	Benitec Biopharma Inc	100.00%
BPTH	Bio Path Holdings Inc	-11.11%